RF
47
4
VIX
33
3
SEE
42
2
KMI
63
8
URBN
67
-3
VFC
58
13
DGX
33
2
HPE
44
-2
FTI
79
3
EW
38
-2
SRCL
54
-13
AES
54
3
APA
21
-4
MDT
42
-2
ETR
52
6
KEY
39
6
SYY
57
4
WHR
59
2
CHRW
44
2
EMR
50
2
RF
47
4
VIX
33
3
SEE
42
2
KMI
63
8
URBN
67
-3
VFC
58
13
DGX
33
2
HPE
44
-2
FTI
79
3
EW
38
-2
SRCL
54
-13
AES
54
3
APA
21
-4
MDT
42
-2
ETR
52
6
KEY
39
6
SYY
57
4
WHR
59
2
CHRW
44
2
EMR
50
2
Financhill
Back

BioXcel Therapeutics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
11

BTAI
BioXcel Therapeutics

Last Price:
1.20
Seasonality Move:
-23.4%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
11
BioXcel Therapeutics (BTAI) is a Sell

Is BioXcel Therapeutics a Buy, Sell or Hold?

  • The current BioXcel Therapeutics [BTAI] share price is $1.21. The Score for BTAI is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BTAI Stock Price Chart

What is BioXcel Therapeutics's stock price today?

  • The BioXcel Therapeutics share price today is $1.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

BTAI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 23.06 Sell
Chaikin Money Flow: 232872 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.31 - 1.89) Sell
Bollinger Bands (100): (1.86 - 3.18) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.89 - 42.13) Sell
Bollinger Bands (100): (40.93 - 48.81) Sell

BTAI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.28 Sell
20-day SMA: 1.51 Sell
50-day SMA: 2.05 Sell
200-day SMA: 2.9 Sell
8-day EMA: 1.27 Sell
20-day EMA: 1.5 Sell
50-day EMA: 1.92 Sell
200-day EMA: 4.37 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

BioXcel Therapeutics Earnings Growth & BTAI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.18 per share, an increase this year of $3.38 per share, and an increase next year of $0.97 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

BioXcel Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):